Home NDC 59572-775 Reblozyl
Product NDC 59572-775
11-digit product format 595720775
Labeler code 59572
Product ID 59572-775_769ec39a-61bd-4726-b14a-9594897baa67
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Luspatercept
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route SUBCUTANEOUS
Labeler Celgene Corporation
Application BLA761136
Marketing category BLA
Marketing start 2019-11-08
Substance LUSPATERCEPT
Active strength 75 mg/1
Pharmacologic classes Erythroid Maturation Agent [EPC], Increased Erythroid Cell Production [PE]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Reblozyl
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LUSPATERCEPT 75 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination AQK7UBA1LS Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2262906 Internal RxNorm lookup 2262911 Internal RxNorm lookup 2262913 Internal RxNorm lookup 2262915 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59572-775-01 Reblozyl 1 in 1 VIAL, GLASS INJECTION, POWDER, LYOPHILIZED, 1 20 59572-775-01 Reblozyl 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 20
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59572-775 REBLOZYL (LUSPATERCEPT) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CELGENE CORPORATION] 19 Current NDC, Legacy NDC, 2 package rows 20240530_82f4d266-3f52-41eb-86ba-0abf3cf468e8.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761136 Reblozyl luspatercept-aamt 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 59572-775-01 59572077501 1 VIAL, GLASS in 1 CARTON (59572-775-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS 2019-11-08 0000-00-00 No No Current